Join to view full profile
1500 East Medical Center DrB1 floor Cancer Recp CAnn Arbor, MI 48109
Phone+1 734-647-8902
Dr. Schuetze is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1996 - 1999
Duke University HospitalResidency, Internal Medicine, 1993 - 1996
Oregon Health and Science University School of MedicineClass of 1993
Certifications & Licensure
MI State Medical License 2004 - 2029
NC State Medical License 1993 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
- Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
- Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Publications & Presentations
PubMed
- A pooled analysis of phase 2 clinical trials in advanced chordoma.Gregory M Cote, Corrine F Elliott, Astrid Lipplaa, Hans Gelderblom, Jean-Yves Blay
European Journal of Cancer. 2026-08-26 - Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.Priscilla Merriam, James J Morrow, Emanuele Mazzola, Nicole L Solimini, Prafulla C Gokhale
Nature Medicine. 2026-06-01 - Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.Nadeem R Abu-Rustum, Susana M Campos, Sudha Amarnath, Rebecca Arend, Emma Barber
Journal of the National Comprehensive Cancer Network. 2026-03-01
Journal Articles
- Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Francis Worden, Scott M Schuetze, Mark M Zalupski, Vaibhav Sahai, Ajjai Alva, Anne F Schott, Moshe Talpaz, JAMA Oncology
- Efficacy and Tolerability of Trabectedin in Elderly Patients with Sarcoma: Subgroup Analysis from a Phase 3, Randomized Controlled Study of Trabectedin or Dacarbazine ...A Elias, M Milhem, S Patel, S M Schuetze, M L Hensley, Annals of Oncology
Press Mentions
AHA News: Cancers of the Heart Are Rare -- and Here's WhyFebruary 25th, 2019
Liposarcoma, Rare Cancer That Took Rob Ford’s Life, Hard to Treat: OncologistMarch 22nd, 2016
Grant Support
- Early Phase Clinical Cancer Prevention ConsortiumUNIVERSITY OF MICHIGAN AT ANN ARBOR2020–2031
- Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatmentUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
